Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$68.3BHealthcare Market cap, Sector
ResMed
RMD$27.36BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsRMD
84B
B72
87A
B75
92A
B75
66C
D58
75B
D47
91A
C69
95A
B73
Side-by-side metrics
| Metric | JSLL.NS | RMD |
|---|---|---|
| Market cap | Winner: $68.3B | $27.36B |
| P/E (TTM) | 33.3x | 19.6x Winner |
| EV/EBIT | 24.1x | 17.1x Winner |
| ROIC (TTM) | Winner: 39.15% | 19.63% |
| Gross margin | Winner: 88.58% | 61.69% |
| Net margin | Winner: 27.68% | 27.44% |
| Revenue CAGR 5y | Winner: 57.81% | 12.64% |
| EPS CAGR 5y | Winner: 86.67% | 30.73% |
| Debt / Equity | 0.3x | 0.1x Winner |
| Dividend yield | - | 1.14% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Revenue CAGR 5y57.81%vs 12.64%+78%
- EPS CAGR 5y86.67%vs 30.73%+65%
- Market cap$68.3Bvs $27.36B+60%
- ROIC (TTM)39.15%vs 19.63%+50%
RMD leads on
- Debt / Equity0.1xvs 0.3x+52%
- P/E (TTM)19.6xvs 33.3x+41%
- EV/EBIT17.1xvs 24.1x+29%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.